Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo

Osteosarcoma typically arises in tissues of mesenchymal origin, and is the most malignant bone tumor characterized by high local aggressiveness, with poor therapeutic outcome. Busulfan has been widely used to treat CML. So far, there are no reports on the therapeutic effect of busulfan on osteosarco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Qiang, Li, Fang, Quan, Hongyu, Liu, Yunlai, Xu, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317920/
https://www.ncbi.nlm.nih.gov/pubmed/24815002
http://dx.doi.org/10.1111/cas.12436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317920/
https://www.ncbi.nlm.nih.gov/pubmed/24815002
http://dx.doi.org/10.1111/cas.12436

Ejemplares similares